Van Plew Daniel P sold REGN
February 14, 2024 · Form 4 insider transaction
Van Plew Daniel P sold 226 shares of Regeneron Pharmaceuticals, Inc. at $938.13 per share, a transaction worth $212.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
226
Price
$938.13
Total value
$212.0K
InsiderVan Plew Daniel P
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 14, 2024
Filing dateFebruary 16, 2024
Shares owned after30,147
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.